Loading clinical trials...
Loading clinical trials...
An Open-Label, Multicenter, Rollover Study to Evaluate the Safety and Tolerability of Long-Term Administration of Gantenerumab in Participants With Alzheimer's Disease
Conditions
Interventions
Gantenerumab
Locations
56
United States
Banner Sun Health Research Insitute
Sun City, Arizona, United States
California Neuroscience Research Medical Group, Inc
Sherman Oaks, California, United States
Accelerated Enrollment Solutions
Orlando, Florida, United States
University of South Florida
Tampa, Florida, United States
Bioclinica The Villages
The Villages, Florida, United States
Western Michigan University Homer Stryker M.D. School of Medicine Center for Clinical Research
Kalamazoo, Michigan, United States
Start Date
May 22, 2020
Primary Completion Date
January 4, 2023
Completion Date
January 4, 2023
Last Updated
January 18, 2024
NCT07545473
NCT04570085
NCT07531732
NCT07290387
NCT06501495
NCT06121544
Lead Sponsor
Hoffmann-La Roche
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions